ORIGINAL RESEARCH
Published on 24 Dec 2024
Optimized BCMA/CS1 bispecific TRuC-T cells secreting IL-7 and CCL21 robustly control multiple myeloma
doi 10.3389/fimmu.2024.1502936
- 3,811 views
- 2 citations
- Frontiers in Hematology
- Blood Cancer
- Research Topics
- Understanding Complications and Outcomes of Anti-BCMA Treatments in Relapsed Multiple Myeloma
Understanding Complications and Outcomes of Anti-BCMA Treatments in Relapsed Multiple Myeloma
2,892
Total downloads
12k
Total views and downloads
